The US is the best place for a business to invest, the boss of one of the UK's biggest pharmaceutical companies has said.
India and the US possess immense potential for healthcare collaboration in AI, drug development, and medical hardware, ...
In a little over ten years, organoid models—miniature, lab-grown clusters of cells that imitate real organs—have transformed how we study human development and disease while accelerating drug ...
Formularies continue to increase in complexity, and changes to those formularies are especially challenging for consumers to navigate.
Food and Drug Administrator Marty Makary said he has a "moral duty" to inform the public of the risks of the COVID-19 vaccine ...
Carlton V. Bell II won second place in GLAAD + STARZ TV Pilot Pitch Competition with a series that will destigmatize HIV.
Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.
Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...
Opinion
The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health
In the ongoing debate over regulatory reform, the MAHA Commission’s proposal to eliminate FDA user fees has sparked renewed scrutiny of ...
A new start-up called PsiThera has spun out of Roivant Sciences with $47 million and a computational drug discovery platform ...
A large, multi-institution study led by a Brown University physician-scientist could have important implications for the ...
The investigational orexin receptor 2 (OX2R) agonist oveporexton improved cognitive symptoms of narcolepsy type 1 (NT1) in secondary analysis of a phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback